Equities

Control Bionics Ltd

CBL:ASX

Control Bionics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.05
  • Today's Change0.00 / 0.00%
  • Shares traded32.63k
  • 1 Year change-47.20%
  • Beta0.7734
Data delayed at least 20 minutes, as of May 10 2024 04:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Control Bionics Limited is a medical device company engaged in the development, commercialization and sale of assistive communications technology systems within the disability sector. It assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.

  • Revenue in AUD (TTM)6.43m
  • Net income in AUD-4.82m
  • Incorporated2005
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VIP Gloves Ltd5.17m-15.35m2.36m4.00------0.4564-0.0195-0.01950.00660.00050.33078.4412.67---98.16-9.23-160.84-16.91-62.5817.80-296.82-10.080.2919-49.790.798---77.542.47-256.38---13.66--
Imagion Biosystems Ltd1.65m-13.07m2.42m--------1.47-0.4281-0.42810.0532-0.14350.226--19.80---179.45-78.58-365.28-94.74-----794.13-1,111.01---9.872.91--188.6634.67-33.22--17.90--
Allegra Medical Technologies Ltd-1.07m-2.69m3.47m4.00k---------0.0245-0.0395-0.0098-0.0135-0.3718-------93.15-21.72-2,036.46-29.07--58.84---49.44---6.88----1,200.00-87.74-3.50---49.57--
Visioneering Technologies Inc13.12m-5.22m5.75m----0.6311--0.4381-0.1544-0.15440.38430.16641.041.9510.25---41.20-76.38-50.73-97.7054.9044.90-39.80-98.702.85--0.00--19.0121.3641.05------
Uscom Ltd3.39m-2.10m5.87m11.00--2.13--1.73-0.0119-0.01190.01920.01130.53880.66786.87---33.36-28.64-48.04-33.7184.2085.58-61.91-49.931.31-21.480.5863--3.63-0.8707-31.36---8.50--
Bluechiip Ltd720.41k-5.85m6.60m7.00--4.25--9.17-0.0068-0.00680.00080.00140.14810.12070.7382---120.26-50.46-305.73-61.9864.1760.32-812.09-605.140.265-58.500.2676---1.3210.26-64.78--9.49--
Inhalerx Ltd1.21m-1.44m7.59m----11.41--6.29-0.0076-0.00760.00640.00350.629--2.89---75.27-80.34-112.38-99.88-----119.67-500.13---175.270.4571--2,226.0922.7925.10------
Control Bionics Ltd6.43m-4.82m8.53m----0.9402--1.33-0.0471-0.04710.06260.05320.64431.983.75---48.27-35.68-54.75-38.8176.5166.18-74.92-96.312.89-293.800.0101--25.1545.937.70--99.91--
Osteopore Ltd2.22m-4.87m9.48m----11.62--4.27-0.0901-0.09010.04150.00750.63862.083.23---140.31---387.70--73.78---219.71--0.6869-448.580.7165--31.02---16.13------
Data as of May 10 2024. Currency figures normalised to Control Bionics Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.